Plant natriuretic peptide A for improved plant grafting and tissue regeneration
A novel peptide-based tool to enhance grafting efficiency by suppressing wound-induced salicylic acid signaling, promoting tissue regeneration in Arabidopsis, tomato, and watermelon.
Overview
This research proposes Plant Natriuretic Peptide A (PNP-A) as a novel exogenous tool to improve plant grafting outcomes. Grafting is a widely used horticultural technique to create resilient, non-transgenic chimera plants, but its success is limited by wound-induced salicylic acid (SA), which acts as an intrinsic inhibitor of tissue regeneration. PNP-A is a small peptide capable of suppressing SA signaling when applied externally, offering a practical approach to overcoming this biological barrier and boosting grafting efficiency across multiple crop species.
Technical specifications
- Target mechanism: Suppression of wound-induced salicylic acid (SA) signaling at cutting sites to remove a key barrier to tissue regeneration
- Active molecule: PNP-A, a 34-amino acid peptide identified as the only known small molecule capable of exogenously suppressing SA signaling
- Species coverage: PNP-A orthologues are present in Arabidopsis, tomato, and watermelon, enabling application across model and commercially grafted crops
- Application method: Direct application of mature PNP-A peptides or mutated variants onto cutting sites to monitor tissue regeneration and reunion
- Validation approach: RNAseq profiling to assess the systematic impact of PNP-A on wounded tissue and the hormonal dynamics during grafting
- Preliminary evidence: Spraying PNP-A on Arabidopsis suppressed an SA reporter; reducing SA signaling in Arabidopsis and N. benthamiana resulted in high root regeneration; SA response genes were activated within 30 minutes after cutting
Technology readiness level
This technology is at an early-to-mid stage of development. Preliminary data from Arabidopsis and N. benthamiana have established proof of concept that reducing wound-induced SA promotes tissue regeneration. The next phase involves synthesizing PNP-A orthologues from Arabidopsis, tomato, and watermelon, followed by testing their efficacy on grafting efficiency in all three species. Further RNAseq analysis will characterize the systematic molecular effects of PNP-A on wounded tissue. The technology has not yet been validated in commercial-scale grafting operations.
About University of Georgia
The University of Georgia is a comprehensive public land‑grant research university serving a large student body across multiple campuses, known for applied scholarship and community partnership. Industry partners access core facilities and pilot‑scale capabilities—including the Food Product Innovation and Commercialization Center—for prototyping, scale‑up, and product validation. A downtown Innovation District and a statewide Cooperative Extension network link campus expertise to companies across Georgia, while proximity to Atlanta’s corporate and logistics hubs lowers barriers to engagement. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office provides IP services, licensing, startup support, and incubator space to accelerate commercialization.
delivered to your inbox.